Advanced Filters
noise

Migraine Clinical Trials

A listing of Migraine medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 169 clinical trials
M Muhammad Zia-ur-Rehman, PCPS

Comparative Efficacy of Flunarizine and Propanolol in Pediatric Migraine

Flunarizine and propranolol have demonstrated efficacy in reducing migraine frequency across age groups, though evidence in pediatric populations remains limited and inconsistent. Therefore, the current study has been planned to evaluate and compare the effectiveness of flunarizine and propranolol in reducing migraine frequency in children aged 8-15 using the Pediatric …

8 - 15 years of age All Phase N/A
L Lise Laclautre

Tryptophan as a Modulating Factor in the Antimigraine Efficacy of Triptans

Migraine is a leading cause of disability, and while triptans are commonly used to treat migraine attacks, over 20% of patients don't respond well to them. This study aims to understand why some people don't benefit from triptans. One key focus is tryptophan, an amino acid that plays a role …

18 - 50 years of age All Phase N/A
S Sahar TaghipourAzam, PT

Online Hatha Yoga Program as an Add-On Therapy for Episodic High-Frequency Migraine

This randomized controlled trial aims to evaluate the effectiveness and feasibility of an online Hatha yoga program as an adjunct (add-on) therapy for patients with high-frequency episodic migraine. Participants will be randomly assigned to either an intervention group receiving a 12-week home-based online Hatha yoga program in addition to usual …

18 - 65 years of age All Phase N/A
C Capu Motion: Die Physio- und Ergotherapeuten GbR Capu Motion

Multimodal Physiotherapy Intervention for People With Migraine

Migraine is one of the most prevalent primary headache disorders worldwide and is associated with substantial impairments in quality of life, work productivity, and psychosocial functioning. In Germany alone, nearly 18 million people are affected. Although pharmacological therapy remains a cornerstone of migraine management, non-pharmacological interventions-particularly physiotherapy-play an important role …

18 - 70 years of age All Phase N/A
G Gianluca Coppola, MD, PhD, Prof.

Chronology and Sequence of Premonitory Symptoms

The purpose of this study is to prospectively investigate the temporal sequence of premonitory symptoms across multiple migraine attacks.

18 - 65 years of age All Phase N/A
E EVO756-MIG001 Research Site

Study of EVO756 in Adults With Migraine

This study will evaluate the efficacy and safety of EVO756 against placebo in adults with migraine.

18 - 64 years of age All Phase 2
Y Yasemin Karaaslan

Basic Body Awareness Therapy in Individuals With Migraine

One biopsychosocial approach proven effective in headache treatment is basic body awareness therapy. This study was planned to evaluate the effectiveness of basic body awareness training and lifestyle recommendations in individuals diagnosed with migraine. Functional status will be assessed using the Migraine-Related Disability Assessment Scale (MIDAS), sleep quality using the …

18 - 55 years of age All Phase N/A
E Eken

Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder Delivered Via a Multidose Dry Powder Inhaler) for the Acute Treatment of Migraine in Adult Patients

This study is testing an investigational inhaled migraine medication to see how well it works, how safe it is, and how well people tolerate it. Adults with migraine will receive both the study medication (ASY202) and a placebo (inactive treatment) at different times during the study. Neither participants nor study …

18 - 65 years of age All Phase 2

A Study to Compare the Blood Levels of Two Dosage Formulations of the Study Medicine in Healthy Adults

The purpose of this study is to assess the bioequivalence of an alternative ODT formulation (ODT2) versus the approved ODT formulation of a CGRP receptor antagonist in healthy adult participants under fasting conditions.

18 years of age All Phase 1
A Alberto Doretti, MD

Evaluation of the Performance of the Doraldo-Castelletti Scale in Supporting the Neurologist's Decision to Refer Migraine Patients to Physiotherapy

Migraine is the leading cause of disability worldwide among people aged 15 to 49. Although therapies targeting the CGRP pathway have improved the management of the condition, there are large groups of patients who do not respond to medications or for whom these are contraindicated. In this context, non-pharmacological therapies …

18 - 70 years of age All Phase N/A

Simplify language using AI